MoneyWorks4Me

Orchid Pharma - Quaterly Results

09 Feb 2023 Evaluate
The total revenue for the quarter ended December 2022 remained nearly unchanged at Rs. 1597.60 millions.The Total Profit for the quarter ended December 2022 of Rs. 67.28 millions grew from Rs.-87.48 millionsThe company reported a good operating profit of 225.89 millions compared to 182.57 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1597.60 1592.95 0.29 4559.98 3767.40 21.04 5569.74 4506.95 23.58
Other Income 89.31 23.66 277.47 177.01 72.56 143.95 90.03 64.61 39.34
PBIDT 225.89 182.57 23.73 616.33 350.38 75.90 662.62 643.62 2.95
Interest 76.80 67.81 13.26 247.41 275.53 -10.21 320.12 513.36 -37.64
PBDT 149.09 114.76 29.91 368.92 74.85 392.88 342.50 130.26 162.94
Depreciation 81.81 202.24 -59.55 475.74 603.94 -21.23 870.21 1088.99 -20.09
PBT 67.28 -87.48 -176.91 -106.82 -529.09 -79.81 -527.71 -958.73 -44.96
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 67.28 -87.48 -176.91 -106.82 -529.09 -79.81 -527.71 -958.73 -44.96
Equity 408.16 408.16 0.00 408.16 408.16 0.00 408.16 408.16 0.00
PBIDTM(%) 14.14 11.46 23.37 13.52 9.30 45.33 11.90 14.28 -16.69
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1146.00
Cipla 1360.00
Lupin 2046.00
Zydus Lifesciences 1106.10
View more..